To read the full story, subscribe or sign in.

EC approves first drug for nonradiographic severe axial spondyloarthritis

July 31, 2012

BioWorld Science Regulatory Musculoskeletal

Today's news in brief

BioWorld briefs for July 31, 2026.

Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...

Silhouette illustration of DNA gene editing

Death in Chinese gene-editing trial exposes ethical fault lines

BioWorld

The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...

Fauci’s silence may put him in contempt of Congress

BioWorld

After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...

Seed funding at Adjuvia to treat mitochondrial dysfunction

BioWorld Science

Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...